Asia
TLC announced that it has for the fifth consecutive year been ranked in the top 5% of companies for Corporate Governance Evaluation by the Taiwan Stock Exchange Corporation and Taipei Exchange.
Apollomics, Inc. announced that Fabio M. Benedetti, M.D. has joined the senior leadership team as Chief Medical Officer (CMO).
Eisai Co., Ltd has bought out Purdue Pharma L.P.'s rights in the worldwide collaboration for the development and commercialization of lemborexant, an investigational sleep-wake regulation agent being studied for the treatment of multiple sleep-wake disorders, including insomnia and irregular sleep-wake rhythm disorder (ISWRD) in patients with Alzheimer Disease.
Pharma, biotech and life science companies from across the globe share data and progress on pipelines and other company events.
Teva Pharmaceuticals recalled 35 lots of bulk Losartan Potassium after a known carcinogen was discovered in the active pharmaceutical ingredient.
The federal anti-kickback statute prevents pharmaceutical companies from providing financial coverage of Medicare copay payments that would encourage patients to purchase a company’s medication.
Singapore scientists are developing a single test that can detect and differentiate multiple mosquito-borne viruses and their types
Scientists from the Agency for Science, Technology and Research’s (A*STAR), Genome Institute of Singapore (GIS), together with scientists from Duke-NUS Medical School and A*STAR’s Bioinformatics Institute (BII), have mapped out the structures of four dengue and four Zika viruses.
ADC Therapeutics to develop next-generation masked antibody drug conjugates (ADCs), incorporating Adagene’s SAFEbody™ technology, with potential utility across multiple tumor types
Recognized for Taking on Challenge of Transformation to New Business Models by Integrating Management and Ict Strategies
PRESS RELEASES